We start this edition of our newsletter with a new study that strengthens the link between gut bacteria and depression, in a first step towards understanding how the gut microbiome and its metabolites might affect mood in humans. You will also find the main findings and achievements of the European Union-funded microbiome project MyNewGut, which has come to an end after five years looking at the gut microbiota’s influence on energy balance, brain development, diet-related diseases and behavior.
Next up, a recent review that updates current scientific evidence regarding the factors involved in explaining gut microbiota composition variation in the same individual and between individuals, both in terms of health and disease. Also in this newsletter, a new study which has now provided the largest ever catalog of human-associated microbes across worldwide populations.
Finally, we have a new article highlighting research that has identified 11 bacterial strains from the human gut microbiota that enhance resistance to Listeria infection and improve the antitumor efficacy of checkpoint inhibitors in mice.
The GMFH publishing team